Sepsis Solutions

The National Institute of General Medical Sciences reports that over 1 million people in the United States fall victim to severe sepsis each year, and 15%–30% of cases result in death. With sepsis, every minute counts, making early detection the best hope for ending sepsis fatalities and injuries. When patients receive appropriate treatment within 2 hours after initiation of care, the survival rate is 60%. But extend that diagnosis to treatment time to 4 hours, and the survival rate reduces to a startling 30%.

bioMérieux's Solutions and Commitment

bioMérieux has developed a complete range of diagnostic solutions dedicated to helping clinicians diagnose sepsis as quickly and as accurately as possible, as well as educating patients and raising awareness about the dangers of this condition. Sepsis truly is a race against the clock, and we have continued to introduce innovative solutions, which have led to improved sepsis diagnosis.

Reading Guide >

Group B Strep
CHROMID® Reading Guide

Group B Strep can cause bacteremia and sepsis. Chromogenic media, like bioMérieux’s CHROMID® Strepto B, are a widely used tool in screening for GBS. Download the guide to learn more.

Download Booklet >

PCT-Guided Antibiotic Therapy For Sepsis

PCT provides critical biomarker information that can help increase the accuracy of early sepsis diagnosis and assess host response to bacterial infection.

Watch Video >

PCT-Guided Antibiotic Therapy for Patients with Sepsis

The use of PCT can increase accuracy of early diagnosis and enable more appropriate clinical decisions. Watch the video to learn more.

The Power of Diagnostics

There is no singular solution for the detection of sepsis because it can be caused by different pathogens, some of which may not respond to antibiotics. Early diagnostic intelligence is helping shorten the time to treatment and allowing hospitals to optimize patient care with the right antibiotic therapy at the right time. This includes ongoing surveillance capabilities that support the timely discontinuation of treatment— minimizing the risks and impact of antibiotic overuse. Sepsis and antimicrobial resistance have become a dual public health crisis, and rapid diagnostics play a pivotal role is winning the fight against both conditions.

Visit Website >

Sepsis Alliance

We are proud to support the Sepsis Alliance and their dedication to producing education for healthcare professionals to increase sepsis awareness.

Read Article >

September is Sepsis Awareness Month

bioMérieux Connection will host several articles about sepsis during the month of September. Help us continue to raise awareness of sepsis during September.

Watch Video >

What is Sepsis?

This engaging animated video goes over the different types of sepsis, how it occurs, and possible symptoms.